Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock
Tweet Send to a Friend
Bernstein raised its price target on a major pharmaceutical company to $1,385 from $1,300 on Monday, maintaining an Outperform rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
